Onderzoeker
Armand Van Deun
- Trefwoorden:B230-bacteriologie, B680-volksgezondheid, B725-diagnostiek, B726-klinische-biologie
Affiliaties
- Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf31 dec 1998 → 29 nov 2018 - Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf31 dec 1998 → 16 apr 2015
Projecten
1 - 4 of 4
- Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without Creating MoreVanaf1 okt 2018 → Heden
- Trend and significance of INH resistance in DF BdeshVanaf1 jan 2018 → 31 dec 2018
- Trend of fluoroquinolone resistance among the MDR in DF BangladeshVanaf1 jan 2017 → 31 dec 2018
- Validity and feasability of use of a rapid and innovative test for detection of Multi Drug Resistant (MDR) TB cases in Kinshasa, DRCVanaf1 mrt 2009 → 6 jul 2018
Publicaties
41 - 50 van 142
- Comment on: Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study(2018)
Auteurs: Tom Decroo, Armand Van Deun, Lut Lynen
Pagina's: 1733-1734 - Principles for constructing a tuberculosis treatment regimen(2018)
Auteurs: Armand Van Deun, Tom Decroo, A Piubello, Bouke C de Jong, Lut Lynen, H L Rieder
Pagina's: 239-245 - Xpert Ultra can unambiguously identify specific rifampin resistance-conferring mutations(2018)
Auteurs: Armand Van Deun, Conor J. Meehan, Michèle Driesen, Siemon Gabriëls, Leen Rigouts, Emmanuel André, Bouke de Jong
- Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations(2018)
Auteurs: Pauline Lempens, Conor J. Meehan, Koen Vandelannoote, Kristina Fissette, Pim De Rijk, Armand Van Deun, Leen Rigouts, Bouke de Jong
- Twenty years of rifampicin resistance surveillance in Bangladesh: periodic vs. continuous monitoring(2018)
Auteurs: A Van Deun, K.J.M. Aung, M.A. Hossain, M. A. H. Salim, Mourad Gumusboga, Bouke de Jong, Tom Decroo
Pagina's: 1450-1461 - Exploratory results of intensification of the use of the GeneXpert (R) MTB/RIF as support in the tracking the TB and TB-RR in Kinshasa(2017)
Auteurs: A. Bele, S. Musala, L. Okenge, J. C. Kasereka, J. F. Baleka, Brian Bakoko, Armand Van Deun, M Kaswa
Pagina's: 212-212 - Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance(2017)
Auteurs: Armand Van Deun, Chen-Yuan Chiang
- How should discordance between molecular and growth-based assays for rifampicin resistance be investigated?(2017)
Auteurs: S. Hofmann-Thiel, H Hoffmann, D. Hillemann, Leen Rigouts, Armand Van Deun, Katharina Kranzer
Pagina's: 721-726 - Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis(2017)
Auteurs: Hans L. Rieder, Armand Van Deun
Pagina's: 123-124 - Detection of Rifampicine resistance mutations in the 81 bp RRDR of rpoBGene in Mycobacterium tuberculosis using Xpert MTB/RIF in Kinshasa, DRC: a retrospective study(2017)
Auteurs: S. Musala, A. Bele, L. Okenge, J. C. Kasereka, Muriel Aloni, Armand Van Deun, M Kaswa
Pagina's: 212-212